KILITCH DRUGS (INDIA)
Back to Balance Sheet
|
KILITCH DRUGS (INDIA) Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹84 Cr | ₹64 Cr | ₹69 Cr | ₹69 Cr | ₹73 Cr |
What is the latest Total Current Liabilities ratio of KILITCH DRUGS (INDIA) ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹84 Cr |
| Mar2024 | ₹64 Cr |
| Mar2023 | ₹69 Cr |
| Mar2022 | ₹69 Cr |
| Mar2021 | ₹73 Cr |
How is Total Current Liabilities of KILITCH DRUGS (INDIA) Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹84 Cr | 31.29 | |
| Mar2024 | ₹64 Cr | -6.76 | |
| Mar2023 | ₹69 Cr | -0.59 | |
| Mar2022 | ₹69 Cr | -5.51 | |
| Mar2021 | ₹73 Cr | - | |
Compare Total Current Liabilities of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹560.0 Cr | 2.3% | -10.1% | 2.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,999.0 Cr | 3.6% | 7% | 15.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,139.0 Cr | 1.1% | 5.8% | 14.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,791.0 Cr | 1.9% | 12.3% | 49.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,664.0 Cr | 1.8% | 5.9% | 14.8% | Stock Analytics | |
| CIPLA | ₹107,685.0 Cr | 1.6% | 0.2% | -5.4% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | 2.3% |
-10.1% |
2.2% |
| SENSEX | -2.5% |
-6.1% |
7% |
You may also like the below Video Courses